510(k) Report

510(k) · Cleared

Cleared

Aurora MR-Guided Interventional System

K023686510(k) TraditionalCleared Jan 29, 200389-day reviewClass II21 CFR 892.1000

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aurora Imaging Technology, Inc. · LNH System, Nuclear Magnetic Resonance Imaging

Cleared on Jan 29, 2003 as substantially equivalent to K010570 (Mri Devices Corp., 2001) and 1 other predicate after an 89-day review. Its family tree reaches back 1 generation to 2000.

Decided
Jan 29, 2003
Review
89 days
Class
Class II
Product code
LNH
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K000832 (2000). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2001: 1 other ancestorK000832 · Sterotactic Localization Device (SLD) · Philips Medical Systems North America, Inc. · 2000200020022004
Other ancestors, by generation 1 generation back: 1 other ancestor K000832 · Sterotactic Localization Device (SLD) · Philips Medical Systems North America, Inc. · 20000
  1. Root · 1 generation backK000832 Sterotactic Localization Device (SLD)Philips Medical Systems North America, Inc. · 2000
  2. This deviceK023686 Aurora MR-Guided Interventional SystemAurora Imaging Technology, Inc. · 2003
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K000832Sterotactic Localization Device (SLD)Philips Medical Systems North America, Inc.2000—
0 (this device)K023686Aurora MR-Guided Interventional SystemAurora Imaging Technology, Inc.2003—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
FIG. 1 — Lineage of K023686, 2000–2003Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LNH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LNH device

  1. #1 K213693 MAGNETOM Vida with syngo MR XA50Ascore 23.0 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K010570Breast Immobiization and Biopsy Device MR-Biopsy 160
Summary page 1
…o a magnetic resonance device 3. PREDICATE DEVICES MRI Devices Breast Immobilization and Biopsy Device MR-Biopsy 160 (K010570) Philips Stereotactic Localization Device (K000832) 4. DEVICEDESCRIPTION The use and operation of th…
Mri Devices Corp.2001—
*K000832Sterotactic Localization Device (SLD)
Summary page 1
…VICES MRI Devices Breast Immobilization and Biopsy Device MR-Biopsy 160 (K010570) Philips Stereotactic Localization Device (K000832) 4. DEVICEDESCRIPTION The use and operation of the Aurora@ MR-Guided Interventional System and other MR-guid…
Philips Medical Systems North America, Inc.2000—

Also cleared against K010570: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • 5 other devices also cite its predicate K010570.

How does its category compare?

All LNH devices

LNH System, Nuclear Magnetic Resonance Imaging: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LNH

26in 2025

2007: 122008: 192009: 172010: 122011: 162012: 222013: 192014: 172015: 192016: 202017: 182018: 292019: 262020: 322021: 272022: 302023: 302024: 262025: 262026 (partial year): 24
2007high 32 (2020) · low 12 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LNH

122in 2025

2007: 35 days median2008: 53 days median2009: 70 days median2010: 94 days median2011: 81 days median2012: 89 days median2013: 108 days median2014: 108 days median2015: 140 days median2016: 108 days median2017: 98 days median2018: 128 days median2019: 62 days median2020: 121 days median2021: 87 days median2022: 74 days median2023: 124 days median2024: 104 days median2025: 122 days median2026 (partial year): 126 days median
2007high 140 (2015) · low 35 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LNH

8in 2025

2007: 252008: 122009: 72010: 172011: 112012: 52013: 22014: 132015: 12, 2 Class I2016: 12018: 712019: 52020: 42021: 412022: 132023: 10, 1 Class I2024: 42025: 8, 5 Class I2026 (partial year): 43
2007high 71 (2018) · low 0 (2017)2026

Class I (8 since 2007) Class II/III not classified

Adverse event reports per year · LNH

1,263in 2025

2007: 1142008: 1672009: 1942010: 1652011: 1822012: 1702013: 1072014: 1192015: 1132016: 1352017: 1212018: 1582019: 1582020: 982021: 842022: 1382023: 1592024: 2812025: 1,263
2007high 1,263 (2025) · low 84 (2021)2025

MAUDE reports naming product code LNH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007123525114
2008195312167
200917707194
2010129417165
2011168111182
201222895170
2013191082107
20141710813119
20151914012 (2)113
2016201081135
201718980121
20182912871158
201926625158
202032121498
202127874184
2022307413138
20233012410 (1)159
2024261044281
2025261228 (5)1,263
20262412643—

What is it indicated for?

The Aurora@ MR-Guided Interventional System (the System) is an optional accessory to the Aurora Imaging Technology, Inc., Magnetic Resonance Diagnostic Device. The System is intended to aid in the performance of minimally invasive diagnostic procedures of the lateral or medial side of either breast and adjacent anatomies, which may be facilitated by MR guidance. Such procedures must be performed with MR-compatible devices as selected and evaluated by the clinician.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K023686: Aurora MR-Guided Interventional System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K023686

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026